Anindya Roy Co-founds Lila Biologics to Advance AI-Driven Medical Therapies After Journey from Rural India to UW Lab
Anindya Roy, who moved from rural India to the U.S. in 2008 with limited resources, has co-founded Lila Biologics in 2023 to develop innovative medical therapies using AI-powered protein design. His journey from humble beginnings to a postdoctoral fellowship under Nobel laureate David Baker exemplifies determination and scientific innovation.
Lila Biologics, Nobel Laureate’s Startup, Partners with Eli Lilly to Develop AI-Based Tumor Therapies
Lila Biologics, a startup from Nobel Laureate David Baker's University of Washington lab, is collaborating with Eli Lilly to develop AI-powered tumor-targeted therapies, aiming to deliver a candidate protein for clinical trials within six months. The startup utilizes AI and machine learning platforms to create therapeutic proteins for targeted radiotherapy and long-acting injectable drugs.
Organizations
-
Lila Biologics CEO · current
